Articles Archives - Page 295 of 771

WednesdayJul 27, 2022 9:00 am

Friendable Inc. (FDBL) 360 Artist Platform Sees Growth in Revenue, Traffic and Interest Since January 2022, Driven by FeaturedX Service

Friendable acquired Artist Republik and FeaturedX to compliment the Fan Pass Live brand in January 2022 Since then, Friendable has continued to put focus on the newly acquired brands, paying particular attention to phase II of FeaturedX The company believes that phase II changes are contributing to a revenue increase, with total gross orders received in the first six months of the year reaching approximately $170,000 The global independent artists and performing arts companies market is expected to reach $328.87 billion by 2026, growing at a CAGR of 19% Friendable (OTC: FDBL), a mobile technology and marketing company focused on…

TuesdayJul 26, 2022 1:00 pm

Golden Matrix Group Inc. (NASDAQ: GMGI) Reports Fastest 1QFY2022 Revenue Growth within the Online Gaming Sector

Golden Matrix Group recorded revenue growth of +355% YoY in 1QFY22, the highest growth rate within the online gaming sector Golden Matrix attributed part of the increase to strong revenue contributions from UK-based RKingsCompetitions Ltd, which it purchased an 80% stake in as of November 2021 RKings has emerged as one of the UK’s largest online competition companies, reporting revenues of over $32 million last year The acquisition of RKings bodes favourably for GMGI’s bid to further expand their B2C segment whilst geographically diversifying their revenue stream away from their traditional Asia-Pacific based B2B clientele The online gaming market is…

TuesdayJul 26, 2022 11:15 am

DGE’s AI & Machine Learning For Drug Development Summit To Discuss How AI Can Accelerate Drug Development

With the right skills, suppliers, and foresight, the adoption of AI techniques is shown to accelerate drug pipeline development. To carry forward this important discussion, DGE is organizing the AI & Machine Learning for Drug Development Summit on August 25-26, 2022, as a virtual event. The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. Pharmaceutical, biotech, and medical device professionals are invited to be a part of this event. Eminent industry heads…

TuesdayJul 26, 2022 10:30 am

GeoSolar Technologies Inc. Reinventing the Residential Energy Market

The home energy market represents one of the most overlooked opportunities for sustainable energy investment to dramatically reduce carbon emissions GeoSolar Technologies has developed a patent pending whole-house system using geothermal, solar, and more to transition to energy independent homes The company is preparing a Regulation A+ offering to raise capital ahead With record temperatures in England and heat advisory warnings for one-third of the U.S. recently, there is a lot of chatter about global warming and the need for a more aggressive approach towards reducing carbon emissions. Rising gasoline prices put the emphasis on electric vehicles, but there are…

TuesdayJul 26, 2022 9:45 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Change in Senior Management as the Company Forwards over 100 BTC on Lightning Network

LQwD has 17 active nodes worldwide on the Lightning Network Current nodes include Italy, Indonesia, Canada, France, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and the United States US-West holds the highest capacity at 5.970784520 BTC and a channel count of 115, followed by France, with a capacity of 2.62276941 BTC and 57 channels The cryptocurrency market size was valued at US $1.6 billion in 2021. It is expected to reach US $2.2 billion by 2026, growing at a CAGR of 7.1% over the forecast period LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF),…

TuesdayJul 26, 2022 9:00 am

Odyssey Health, Inc. (ODYY), Determined to Introduce the Market’s First FDA Approved Concussion Treatment Drug

PBS News Hour estimates that, for college students, concussions cost between $446 million and $1.5 billion annually, while for high school students the cost ranges from $5.4 billion to $19.2 billion Odyssey, through its flagship product, PRV-002, hopes to offer the first FDA-approved drug treatment for concussions Once approved, Odyssey is confident that PRV-002 will bring relief to thousands of victims, reduce the cost of concussion treatment and allow victims to lead normal, healthy, and productive lives The company is currently scheduling a meeting with the FDA to present findings from the phase I trial, as it identifies phase II…

MondayJul 25, 2022 12:45 pm

Cub Crafters Inc. Is ‘One to Watch’

CubCrafters owns 15 undeveloped acres at McAllister Field for potential expansion of operations The company recently opened a new 11,000-square-foot Customer Completion Center Cost and timeline of FAA Certification represents a significant barrier to entry The company introduced its CC19-180 XCub aircraft in June 2016, completing the six-year project without using any outside investment The company recently released new variants of the XCub offering floats and more engine horsepower New nosewheel configurations open up the company’s product line to 85% of all pilots Only 10-12% of CubCrafter’s sales are international, though it represents 50% of the market demand – an…

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our…

MondayJul 25, 2022 11:15 am

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage…

MondayJul 25, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Realize ESG Strategies Through Comprehensive Energy Analysis and Environmentally Friendly Upgrades to Facilities

Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas impact CIPI’s Correlate, Inc. and Loyal Enterprises LLC (dba Solar Site Design) subsidiaries provide related help on acquisitions and project development, as well as resource financing A recent report by consulting firm McKinsey & Company forecasts growing adoption of renewable energy solutions by the public,…

Site Search

Company Search

Category: Articles